NIH-funded research Fellowship grant

Understanding how a key enzyme affects DNA viruses

Official title: Identifying a Critical Gatekeeper for DNA Virus Restriction

Funded at University of Texas Hlth Science Center · NIH-10826729 · Data updated 2026-11-12

This study is looking at how a special enzyme called APOBEC3B helps our body fight off DNA viruses, like the Epstein-Barr virus, and how some viruses try to escape its effects, with the hope that this research could lead to new treatments for viral infections.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center
NIH-funded
Lab location1 site (San Antonio, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$38,494
NIH project number1F31AI181573-01
Project IDNIH-10826729 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals affected by DNA virus-related conditions, such as those with Burkitt lymphoma or infections caused by Epstein-Barr virus.

Less likely to help

Patients with viral infections not related to DNA viruses or those without any viral infections may not receive benefits from this research.

What this research studies

This research investigates the role of the enzyme APOBEC3B in fighting DNA viruses, particularly focusing on its ability to mutate viral genomes. The study explores how certain viruses, like Epstein-Barr virus, have developed strategies to evade this enzyme's antiviral effects. By examining the localization of APOBEC3B within cells, the research aims to uncover the mechanisms that enhance its effectiveness against viral infections. Patients may benefit from insights that could lead to new antiviral therapies targeting these mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel antiviral treatments that enhance the body's natural defenses against DNA viruses.

How similar studies have gone: Previous research has shown promising results in understanding the role of APOBEC enzymes in viral restriction, indicating that this approach has potential for success.

Where this research is happening

  • University of Texas Hlth Science Center
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Auerbach, Ashley a — University of Texas Hlth Science Center
  • Study coordinator: Auerbach, Ashley a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.